Cargando…
SUN-303 Effects of Open-Label, Adjunctive Ganaxalone Treatment on Resistant Depression in Postmenopausal Women: A Pilot Study
Resistance to selective serotonin reuptake inhibitor and serotonin norepinephrine reuptake inhibitor treatment occurs in about 50% to 70% of patients with major depressive disorder (MDD), a condition associated with significant morbidity that affects women at higher rates than men. Few well-tolerate...
Autores principales: | Dichtel, Laura E, Nyer, Maren, Dording, Christina, Fisher, Lauren B, Cusin, Christin, Shapero, Benjamin G, Pedrelli, Paola, Kimball, Allison, Rao, Elizabeth M, Mischoulon, David, Fava, Maurizio, Miller, Karen Klahr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207288/ http://dx.doi.org/10.1210/jendso/bvaa046.082 |
Ejemplares similares
-
MON-449 Serum Neuroactive Steroid Levels in Postmenopausal Women with Treatment-Resistant Major Depressive Disorder
por: Dichtel, Laura, et al.
Publicado: (2019) -
MON-286 Peak Stimulated Growth Hormone Is Lower in Subjects with Nonalcoholic Fatty Liver Disease Than Controls of Similar Sex, Age and BMI
por: Dichtel, Laura E, et al.
Publicado: (2020) -
ODP303 Cushing's Syndrome Due to Ectopic Adrenocorticotropic Hormone-Secreting Metastatic Neuroendocrine Tumor
por: Cipriani, Allison, et al.
Publicado: (2022) -
FRI303 PRL-R Variants Are Not Only Associated With Prolactinomas But Also With Dopamine Agonist Resistance
por: de Castro Moreira, Andrea Ramos, et al.
Publicado: (2023) -
MON-303 Giant Growth Hormone Secreting Pituitary Adenomas: A Single Institution Case Series
por: Koylu, Bahadir, et al.
Publicado: (2020)